Company intelligence / Profile preview
Teijin
Tokyo, Tokyo, Japanteijin.com ↗
- Ownership
- Public · 3401
- Employees
- ~20279
- Development stage
- Commercial
01
Overview
Teijin has several approved drugs in Japan and internationally for indications such as type 2 diabetes mellitus ("alogliptin benzoate"), asthma ("ciclesonide"), osteoporosis ("Onealfa", "tacalcitol hydrate"), xerostomia ("sodium chloride/potassium chloride/calcium chloride hydrate/magnesium chloride/dipotassium phosphate"), psoriasis ("tacalcitol hydrate") and constipation ("sodium picosulfate hydrate"). The company submitted an application in December 2024 for palopegteriparatide for hypoparathyroidism.
- Therapeutic areas
- GastroenterologyPulmonologyCardiovascularRheumatologyDermatology
- Modalities
- Small moleculeMonoclonal antibodyEnzyme replacement therapySynthetic peptide
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Ascendis Pharma A/S for palopegteriparatide development/submission in Japan.
04
Financials
- Market cap
- $2.1B
- Total revenue
- $5.5B
- Enterprise value
- $3.2B
Beyond the preview
Go deeper on Teijin.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Teijin.